Response to planned treatment interruptions in HIV infection varies across childhood
Diana M. Gibb(Médecins Sans Frontières), Carlo Giaquinto(University of Padua), M I Gonzales Tomé, Uwe Wintergerst(Centre National de la Recherche Scientifique), S Kanjavanit, Lynda Harper, Nicole Ngo‐Giang‐Huong(Chiang Mai University), Alexandra Compagnucci, Tim Niehues(Helios Klinikum Krefeld), A Sarah Walker(Oxford University Hospitals NHS Trust), Torsak Bunupuradah, Jintanat Ananworanich(Henry M. Jackson Foundation), Hermione Lyall, David Nadal(University of Zurich), María Ángeles Muñoz‐Fernández(Instituto de Salud Carlos III), Jack Moye(National Institutes of Health), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Anita De Rossi, Fabrice Monpoux, Marc Lallemant(Drugs for Neglected Diseases Initiative), Abdel Babiker(MRC Clinical Trials Unit at UCL), Y Saïdi, Nigel Klein(Great Ormond Street Hospital), Janet Darbyshire(MRC Clinical Trials Unit at UCL), Hannah Castro(MRC Clinical Trials Unit at UCL)
Cited by 34
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k